S&P 500   3,131.77 (+0.11%)
DOW   27,099.98 (+0.07%)
QQQ   216.58 (+0.56%)
AAPL   291.45 (+1.17%)
FB   197.34 (+0.29%)
MSFT   169.76 (+1.01%)
GOOGL   1,394.91 (+0.62%)
AMZN   1,972.56 (+-0.01%)
CGC   19.92 (+1.53%)
NVDA   266.86 (+1.84%)
BABA   209.89 (+2.08%)
MU   52.72 (+1.19%)
GE   11.16 (-1.41%)
TSLA   793.30 (-0.83%)
AMD   47.94 (+0.78%)
T   37.25 (-0.29%)
F   7.32 (+1.24%)
NFLX   373.84 (+3.82%)
PRI   121.91 (+0.40%)
BAC   30.86 (-0.71%)
DIS   125.08 (-2.43%)
GILD   72.04 (+2.77%)
S&P 500   3,131.77 (+0.11%)
DOW   27,099.98 (+0.07%)
QQQ   216.58 (+0.56%)
AAPL   291.45 (+1.17%)
FB   197.34 (+0.29%)
MSFT   169.76 (+1.01%)
GOOGL   1,394.91 (+0.62%)
AMZN   1,972.56 (+-0.01%)
CGC   19.92 (+1.53%)
NVDA   266.86 (+1.84%)
BABA   209.89 (+2.08%)
MU   52.72 (+1.19%)
GE   11.16 (-1.41%)
TSLA   793.30 (-0.83%)
AMD   47.94 (+0.78%)
T   37.25 (-0.29%)
F   7.32 (+1.24%)
NFLX   373.84 (+3.82%)
PRI   121.91 (+0.40%)
BAC   30.86 (-0.71%)
DIS   125.08 (-2.43%)
GILD   72.04 (+2.77%)
S&P 500   3,131.77 (+0.11%)
DOW   27,099.98 (+0.07%)
QQQ   216.58 (+0.56%)
AAPL   291.45 (+1.17%)
FB   197.34 (+0.29%)
MSFT   169.76 (+1.01%)
GOOGL   1,394.91 (+0.62%)
AMZN   1,972.56 (+-0.01%)
CGC   19.92 (+1.53%)
NVDA   266.86 (+1.84%)
BABA   209.89 (+2.08%)
MU   52.72 (+1.19%)
GE   11.16 (-1.41%)
TSLA   793.30 (-0.83%)
AMD   47.94 (+0.78%)
T   37.25 (-0.29%)
F   7.32 (+1.24%)
NFLX   373.84 (+3.82%)
PRI   121.91 (+0.40%)
BAC   30.86 (-0.71%)
DIS   125.08 (-2.43%)
GILD   72.04 (+2.77%)
S&P 500   3,131.77 (+0.11%)
DOW   27,099.98 (+0.07%)
QQQ   216.58 (+0.56%)
AAPL   291.45 (+1.17%)
FB   197.34 (+0.29%)
MSFT   169.76 (+1.01%)
GOOGL   1,394.91 (+0.62%)
AMZN   1,972.56 (+-0.01%)
CGC   19.92 (+1.53%)
NVDA   266.86 (+1.84%)
BABA   209.89 (+2.08%)
MU   52.72 (+1.19%)
GE   11.16 (-1.41%)
TSLA   793.30 (-0.83%)
AMD   47.94 (+0.78%)
T   37.25 (-0.29%)
F   7.32 (+1.24%)
NFLX   373.84 (+3.82%)
PRI   121.91 (+0.40%)
BAC   30.86 (-0.71%)
DIS   125.08 (-2.43%)
GILD   72.04 (+2.77%)
Log in

Mylan News Headlines (NASDAQ:MYL)

$19.88
-0.02 (-0.10 %)
(As of 02/26/2020 12:13 PM ET)
Today's Range
$19.86
Now: $19.88
$20.16
50-Day Range
$19.90
MA: $21.64
$22.85
52-Week Range
$16.63
Now: $19.88
$31.58
Volume87,062 shs
Average Volume5.25 million shs
Market Capitalization$10.26 billion
P/E Ratio220.91
Dividend YieldN/A
Beta1.72

Headlines

Mylan (NASDAQ MYL) News Headlines

Source:
DateHeadline
Is a Surprise Coming for Mylan (MYL) This Earnings Season?Is a Surprise Coming for Mylan (MYL) This Earnings Season?
finance.yahoo.com - February 26 at 9:39 AM
Theravance (TBPH) Q4 Earnings Miss, Revenues Beat EstimatesTheravance (TBPH) Q4 Earnings Miss, Revenues Beat Estimates
finance.yahoo.com - February 25 at 5:44 PM
Mylan NV (NASDAQ:MYL) Given Consensus Rating of "Hold" by BrokeragesMylan NV (NASDAQ:MYL) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - February 23 at 10:41 AM
Mylan (MYL) February weekly option implied volatility elevated into EPS and outlook - StreetInsider.comMylan (MYL) February weekly option implied volatility elevated into EPS and outlook - StreetInsider.com
www.streetinsider.com - February 21 at 8:00 PM
3 Best Drugmakers That Are Immune to Coronavirus Fright - Yahoo Finance3 Best Drugmakers That Are Immune to Coronavirus Fright - Yahoo Finance
finance.yahoo.com - February 21 at 3:00 PM
Mylan (MYL) to Release Quarterly Earnings on ThursdayMylan (MYL) to Release Quarterly Earnings on Thursday
www.americanbankingnews.com - February 20 at 3:28 AM
Mylan (MYL) to Report Q4 Earnings: Whats in the Offing? - Yahoo FinanceMylan (MYL) to Report Q4 Earnings: What's in the Offing? - Yahoo Finance
finance.yahoo.com - February 18 at 6:47 PM
Mylan-Upjohn merger filings contemplate coronavirus impact - New York Business JournalMylan-Upjohn merger filings contemplate coronavirus impact - New York Business Journal
www.bizjournals.com - February 18 at 1:46 PM
Mylan (MYL) to Report Q4 Earnings: What's in the Offing?Mylan (MYL) to Report Q4 Earnings: What's in the Offing?
finance.yahoo.com - February 18 at 1:46 PM
Mylan-Upjohn merger filings contemplate coronavirus impactMylan-Upjohn merger filings contemplate coronavirus impact
finance.yahoo.com - February 18 at 1:46 PM
Mylan to Release 2019 Fourth Quarter, Full Year Results and 2020 Guidance on Feb. 27, 2020 - PRNewswireMylan to Release 2019 Fourth Quarter, Full Year Results and 2020 Guidance on Feb. 27, 2020 - PRNewswire
www.prnewswire.com - February 18 at 8:46 AM
Mylan NV (NASDAQ:MYL) Expected to Post Quarterly Sales of $3.21 BillionMylan NV (NASDAQ:MYL) Expected to Post Quarterly Sales of $3.21 Billion
www.americanbankingnews.com - February 15 at 3:08 AM
Pharma Stocks Rally Could Have Legs - Yahoo FinancePharma Stock's Rally Could Have Legs - Yahoo Finance
finance.yahoo.com - February 14 at 1:56 PM
Mylan to hold shareholder vote in April on merger with Upjohn - Pittsburgh Business TimesMylan to hold shareholder vote in April on merger with Upjohn - Pittsburgh Business Times
www.bizjournals.com - February 14 at 1:56 PM
Pharma Stock's Rally Could Have LegsPharma Stock's Rally Could Have Legs
finance.yahoo.com - February 14 at 1:56 PM
Mylan NV (NASDAQ:MYL) Sees Large Increase in Short InterestMylan NV (NASDAQ:MYL) Sees Large Increase in Short Interest
www.americanbankingnews.com - February 13 at 5:26 PM
Mylan NV (NASDAQ:MYL) Expected to Post Earnings of $1.29 Per ShareMylan NV (NASDAQ:MYL) Expected to Post Earnings of $1.29 Per Share
www.americanbankingnews.com - February 13 at 4:39 PM
Will Biogen’s Big Patent Victory Ease Investor Worries About Its Alzheimer’s Drug? - NasdaqWill Biogen’s Big Patent Victory Ease Investor Worries About Its Alzheimer’s Drug? - Nasdaq
www.nasdaq.com - February 11 at 5:42 PM
Will Biogen’s Big Patent Victory Ease Investor Worries About Its Alzheimer’s Drug? - Motley FoolWill Biogen’s Big Patent Victory Ease Investor Worries About Its Alzheimer’s Drug? - Motley Fool
www.fool.com - February 11 at 12:41 PM
Mylan loses patent battle to pharma rival - Pittsburgh Business TimesMylan loses patent battle to pharma rival - Pittsburgh Business Times
www.bizjournals.com - February 10 at 11:33 AM
What's in Store for Acorda (ACOR) This Earnings Season?What's in Store for Acorda (ACOR) This Earnings Season?
finance.yahoo.com - February 10 at 11:33 AM
Mylan NV (NASDAQ:MYL) Insider Sells $267,053.00 in StockMylan NV (NASDAQ:MYL) Insider Sells $267,053.00 in Stock
www.americanbankingnews.com - February 10 at 4:25 AM
Steven Romick Ups Short-Selling in 4th Quarter - Yahoo FinanceSteven Romick Ups Short-Selling in 4th Quarter - Yahoo Finance
finance.yahoo.com - February 7 at 10:42 PM
Steven Romick Ups Short-Selling in 4th QuarterSteven Romick Ups Short-Selling in 4th Quarter
finance.yahoo.com - February 7 at 5:41 PM
Teva (TEVA) to Report Q4 Earnings: What's in the Cards?Teva (TEVA) to Report Q4 Earnings: What's in the Cards?
finance.yahoo.com - February 7 at 12:25 PM
Biogen Soars on Patent Win for MS Drug Tecfidera Over Mylan - Yahoo FinanceBiogen Soars on Patent Win for MS Drug Tecfidera Over Mylan - Yahoo Finance
finance.yahoo.com - February 6 at 3:17 PM
Mylan Breaks Out on the Upside From a 9-Month Base PatternMylan Breaks Out on the Upside From a 9-Month Base Pattern
finance.yahoo.com - February 6 at 10:17 AM
SunTrust Banks Reaffirms Buy Rating for Mylan (NASDAQ:MYL)SunTrust Banks Reaffirms Buy Rating for Mylan (NASDAQ:MYL)
www.americanbankingnews.com - February 6 at 7:45 AM
Biogen Beats Back Mylan Patent Challenge Over MS Drug Tecfidera - TheStreetBiogen Beats Back Mylan Patent Challenge Over MS Drug Tecfidera - TheStreet
www.thestreet.com - February 5 at 5:25 PM
Biogen Rallies On Tecfidera Patent DecisionBiogen Rallies On Tecfidera Patent Decision
feeds.benzinga.com - February 5 at 3:46 PM
Mylan Looks Attractive Heading Into Merger With Pfizers Upjohn - Seeking AlphaMylan Looks Attractive Heading Into Merger With Pfizer's Upjohn - Seeking Alpha
seekingalpha.com - February 5 at 7:24 AM
Beyond travel ban, Mylan sees no disruption to business in China - Pittsburgh Business TimesBeyond travel ban, Mylan sees no disruption to business in China - Pittsburgh Business Times
www.bizjournals.com - February 4 at 11:18 AM
Biogen Investors Face Next Test With Pending Drug Patent RulingBiogen Investors Face Next Test With Pending Drug Patent Ruling
finance.yahoo.com - February 3 at 12:27 PM
Generic Drugs Market 2020 Industry Outlook, Comprehensive Insights, Growth and Forecast 2025 – Market Research EngineGeneric Drugs Market 2020 Industry Outlook, Comprehensive Insights, Growth and Forecast 2025 – Market Research Engine
www.marketwatch.com - February 2 at 12:09 AM
Transdermal Drug Patches Market Huge Growth By Leading Key Players – Mylan (US), UCB (Belgium), Novartis (Switzerland)Transdermal Drug Patches Market Huge Growth By Leading Key Players – Mylan (US), UCB (Belgium), Novartis (Switzerland)
www.marketwatch.com - February 2 at 12:09 AM
European advisory backs two Mylan generics - Seeking AlphaEuropean advisory backs two Mylan generics - Seeking Alpha
seekingalpha.com - January 31 at 7:59 AM
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, FCAU, MYL, OPRA INVESTORS of Lead Plaintiff Deadline in Class Action LawsuitsSHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, FCAU, MYL, OPRA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
finance.yahoo.com - January 29 at 11:08 PM
Pfizer Stock Is One Of The Biggest Pharma Companies — Should You Buy It?Pfizer Stock Is One Of The Biggest Pharma Companies — Should You Buy It?
finance.yahoo.com - January 29 at 8:06 AM
Why the Earnings Surprise Streak Could Continue for Mylan (MYL) - Yahoo FinanceWhy the Earnings Surprise Streak Could Continue for Mylan (MYL) - Yahoo Finance
finance.yahoo.com - January 28 at 7:13 PM
Should Value Investors Buy Mylan (MYL) Stock? - Yahoo FinanceShould Value Investors Buy Mylan (MYL) Stock? - Yahoo Finance
finance.yahoo.com - January 27 at 6:06 PM
Biogens Alzheimers Drug Has Decent Shot At FDA Approval, Analyst Says - BenzingaBiogen's Alzheimer's Drug Has 'Decent Shot' At FDA Approval, Analyst Says - Benzinga
www.benzinga.com - January 27 at 1:05 PM
Is Mylan Stock a Buy? - Motley FoolIs Mylan Stock a Buy? - Motley Fool
www.fool.com - January 25 at 6:54 AM
Pfizer (PFE) Q4 Earnings Coming Up: What's in the Cards?Pfizer (PFE) Q4 Earnings Coming Up: What's in the Cards?
finance.yahoo.com - January 23 at 4:30 PM
Steven Romick Exits Mylan, Cuts Bank of America - Yahoo FinanceSteven Romick Exits Mylan, Cuts Bank of America - Yahoo Finance
finance.yahoo.com - January 20 at 5:51 PM
Should Value Investors Consider Mylan N.V. (MYL) Stock? - NasdaqShould Value Investors Consider Mylan N.V. (MYL) Stock? - Nasdaq
www.nasdaq.com - January 20 at 12:43 PM
Should Value Investors Consider Mylan N.V. (MYL) Stock?Should Value Investors Consider Mylan N.V. (MYL) Stock?
finance.yahoo.com - January 20 at 12:43 PM
Global Heart Transplantation Therapeutics Market 2020-2024: AbbVie Inc, Mylan NV, Pfizer Inc & Teva Pharmaceutical Industries Ltd - ResearchAndMarkets.com - Yahoo FinanceGlobal Heart Transplantation Therapeutics Market 2020-2024: AbbVie Inc, Mylan NV, Pfizer Inc & Teva Pharmaceutical Industries Ltd - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - January 17 at 6:15 AM
Mylan N.V. (MYL) CEO Michael Goettler on 38th Annual J.P. Morgan Healthcare Results Conference Call - Transcript - Seeking AlphaMylan N.V. (MYL) CEO Michael Goettler on 38th Annual J.P. Morgan Healthcare Results Conference Call - Transcript - Seeking Alpha
seekingalpha.com - January 16 at 7:18 AM
Mylan (MYL) call put ratio 2.2 calls to 1 put with focus on January 22 calls as bid ask spreads widen on quick rally - StreetInsider.comMylan (MYL) call put ratio 2.2 calls to 1 put with focus on January 22 calls as bid ask spreads widen on quick rally - StreetInsider.com
www.streetinsider.com - January 15 at 7:39 PM
UPDATE: Mylan (MYL) Spikes Following Comments at Investor Conference - StreetInsider.comUPDATE: Mylan (MYL) Spikes Following Comments at Investor Conference - StreetInsider.com
www.streetinsider.com - January 15 at 7:39 PM
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel